reference/20067041

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20067041

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article
endingPage	761
issn	1524-9557
issueIdentifier	7
pageRange	749-761
publicationName	Journal of immunotherapy (Hagerstown, Md. : 1997)
startingPage	749
bibliographicCitation	Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA, Vasconcelles MJ, Xu Y, Kufe D, Bukowski RM. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J Immunother. 2007 Oct;30(7):749–61. doi: 10.1097/cji.0b013e3180de4ce8. PMID: 17893567.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ac952db92449047efcc96abca61bb44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a236778dc4c98e36f3cd241ecb4ce2d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01cdaa3605c5e867b1ac30fb8595ff93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e985a534dd46817b456360c87db0bb99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5e11ffccb90a0a6121cf0319e2a542c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9db98c12a357d027f2911f865dc2243 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d63ce5c806a5890ce160df26d1f9a52c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a22c2e3d1f639fb97f8eb46091f7a27c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de77ecbf7d099cecc06f82abd085bd8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd61cf5528ebe5b7a352bb8241b1c10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_876a93b15bf437da363805e60b360aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59299312a9cb5addfb36a42aa0000abc
date	200710
identifier	https://doi.org/10.1097/cji.0b013e3180de4ce8 https://pubmed.ncbi.nlm.nih.gov/17893567
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21058 https://portal.issn.org/resource/ISSN/1524-9557
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0024695 http://id.nlm.nih.gov/mesh/M0028986 http://id.nlm.nih.gov/mesh/M0011490
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007680Q000628 http://id.nlm.nih.gov/mesh/D016178Q000276 http://id.nlm.nih.gov/mesh/D019496Q000627 http://id.nlm.nih.gov/mesh/D016219Q000009 http://id.nlm.nih.gov/mesh/D003713Q000276 http://id.nlm.nih.gov/mesh/D002292Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007371Q000378 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D014611 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013601Q000276 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007371Q000276 http://id.nlm.nih.gov/mesh/D007680Q000276 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D017951 http://id.nlm.nih.gov/mesh/D002292Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2a159e809d6704ac0fe2882a7fe64a1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69c8365c5e015aa60518d03ac8157056

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395

Total number of triples: 63.